These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37016935)

  • 1. Hypertension severity, apparent treatment resistant hypertension and hyperuricemia in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.
    Tanner RM; Chaudary N; Colantonio LD; Merriman TR; Reynolds RJ; Bridges SL; Cushman M; Saag K; Limdi N; Muntner P; Howard G; Irvin MR
    J Hypertens; 2023 Jun; 41(6):1033-1039. PubMed ID: 37016935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severity of Hypertension Mediates the Association of Hyperuricemia With Stroke in the REGARDS Case Cohort Study.
    Chaudhary NS; Bridges SL; Saag KG; Rahn EJ; Curtis JR; Gaffo A; Limdi NA; Levitan EB; Singh JA; Colantonio LD; Howard G; Cushman M; Flaherty ML; Judd S; Irvin MR; Reynolds RJ
    Hypertension; 2020 Jan; 75(1):246-256. PubMed ID: 31786980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health care fragmentation and blood pressure control among adults taking antihypertensive medication.
    Colvin CL; Safford MM; Muntner P; Colantonio LD; Kern LM
    Am J Manag Care; 2022 Mar; 28(3):108-115. PubMed ID: 35404546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The contributions of unhealthy lifestyle factors to apparent resistant hypertension: findings from the Reasons for Geographic And Racial Differences in Stroke (REGARDS) study.
    Shimbo D; Levitan EB; Booth JN; Calhoun DA; Judd SE; Lackland DT; Safford MM; Oparil S; Muntner P
    J Hypertens; 2013 Feb; 31(2):370-6. PubMed ID: 23303356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Underutilization of Treatment for Black Adults With Apparent Treatment-Resistant Hypertension: JHS and the REGARDS Study.
    Langford AT; Akinyelure OP; Moore TL; Howard G; Min YI; Hillegass WB; Bress AP; Tajeu GS; Butler M; Jaeger BC; Yano Y; Shimbo D; Ogedegbe G; Calhoun D; Booth JN; Muntner P
    Hypertension; 2020 Nov; 76(5):1600-1607. PubMed ID: 32924633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Social Determinants of Health and Incident Apparent Treatment-Resistant Hypertension Among White and Black US Adults: The REGARDS Study.
    Akinyelure OP; Jaeger BC; Safford MM; Oparil S; Carson AP; Sims A; Hannon L; Howard G; Muntner P; Hardy ST
    J Am Heart Assoc; 2024 May; 13(10):e031695. PubMed ID: 38752519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular Health and Transition From Controlled Blood Pressure to Apparent Treatment Resistant Hypertension: The Jackson Heart Study and the REGARDS Study.
    Akinyelure OP; Sakhuja S; Colvin CL; Clark D; Jaeger BC; Hardy ST; Howard G; Cohen LP; Irvin MR; Tanner R; Carey RM; Muntner P
    Hypertension; 2020 Dec; 76(6):1953-1961. PubMed ID: 33131312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Muntner P; Davis BR; Cushman WC; Bangalore S; Calhoun DA; Pressel SL; Black HR; Kostis JB; Probstfield JL; Whelton PK; Rahman M;
    Hypertension; 2014 Nov; 64(5):1012-21. PubMed ID: 25259745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality.
    Irvin MR; Booth JN; Shimbo D; Lackland DT; Oparil S; Howard G; Safford MM; Muntner P; Calhoun DA
    J Am Soc Hypertens; 2014 Jun; 8(6):405-13. PubMed ID: 24952653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Febuxostat on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension: A Phase 2 Randomized Placebo-Controlled Study.
    Gunawardhana L; McLean L; Punzi HA; Hunt B; Palmer RN; Whelton A; Feig DI
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29102979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of hypertension severity and control with risk of incident atrial fibrillation: The REasons for Geographic And Racial Differences in Stroke (REGARDS) study.
    Garg PK; Wilson N; Yuan Y; Howard VJ; Judd S; Howard G; Soliman EZ
    Clin Cardiol; 2023 Nov; 46(11):1418-1425. PubMed ID: 37605862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incident ESRD and treatment-resistant hypertension: the reasons for geographic and racial differences in stroke (REGARDS) study.
    Tanner RM; Calhoun DA; Bell EK; Bowling CB; Gutiérrez OM; Irvin MR; Lackland DT; Oparil S; McClellan W; Warnock DG; Muntner P
    Am J Kidney Dis; 2014 May; 63(5):781-8. PubMed ID: 24388119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incident Cardiovascular Disease Among Adults With Blood Pressure <140/90 mm Hg.
    Tajeu GS; Booth JN; Colantonio LD; Gottesman RF; Howard G; Lackland DT; O'Brien EC; Oparil S; Ravenell J; Safford MM; Seals SR; Shimbo D; Shea S; Spruill TM; Tanner RM; Muntner P
    Circulation; 2017 Aug; 136(9):798-812. PubMed ID: 28634217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of hyperuricemia on the blood pressure response to antihypertensive agents in hospitalized elderly patients.
    Zhu P; Lin F; Lin C; Hong D; Lin K; Chen H
    J Cardiovasc Med (Hagerstown); 2012 Nov; 13(11):741-6. PubMed ID: 22964647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2017 ACC/AHA Blood Pressure Treatment Guideline Recommendations and Cardiovascular Risk.
    Colantonio LD; Booth JN; Bress AP; Whelton PK; Shimbo D; Levitan EB; Howard G; Safford MM; Muntner P
    J Am Coll Cardiol; 2018 Sep; 72(11):1187-1197. PubMed ID: 30189994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and correlates of low medication adherence in apparent treatment-resistant hypertension.
    Irvin MR; Shimbo D; Mann DM; Reynolds K; Krousel-Wood M; Limdi NA; Lackland DT; Calhoun DA; Oparil S; Muntner P
    J Clin Hypertens (Greenwich); 2012 Oct; 14(10):694-700. PubMed ID: 23031147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apparent Treatment-resistant Hypertension Among Individuals with History of Stroke or Transient Ischemic Attack.
    Howard VJ; Tanner RM; Anderson A; Irvin MR; Calhoun DA; Lackland DT; Oparil S; Muntner P
    Am J Med; 2015 Jul; 128(7):707-14.e2. PubMed ID: 25770032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apparent Treatment Resistant Hypertension Among Stroke Survivors in Ghana.
    Sarfo FS; Ovbiagele B
    J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105401. PubMed ID: 33096498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Apparent Treatment-Resistant Hypertension in the United States.
    Carey RM; Sakhuja S; Calhoun DA; Whelton PK; Muntner P
    Hypertension; 2019 Feb; 73(2):424-431. PubMed ID: 30580690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there an association between the prevalence of atrial fibrillation and severity and control of hypertension? The REasons for Geographic And Racial Differences in Stroke study.
    Bhatt H; Gamboa CM; Safford MM; Soliman EZ; Glasser SP
    J Am Soc Hypertens; 2016 Jul; 10(7):578-586.e5. PubMed ID: 27324843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.